Read the note on page 33 in the Wall Street Resources report
"One note: on that page 33, the expected revenue for the quarter ending January 31st was estimated to be $180,000. EFSF reported $82,930 in the 10Q. " "The street will not take that lightly."
I would normally agree with a statement like that last one when revenues are below expected if it were a company will millions of dollars in revenue per quarter and actual revenue was less than half of expected.
In real numbers, revenue was only $97K below expected, and since they're just starting to build momentum on Cinnergen, it would be understandable for a retailer to delay a purchase they were expecting in the reported quarter for a month or two to see how other retailers' sales of Cinnergen went.